GlassScriptPhysician profile
Ashley Murrey
NPI 1619108420
$1,811.13
in general payments reported to CMS, 2019-2025
19 companies · $37.94 in 2025
The $37.94 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $378 · 2022: $920 · 2023: $475 · 2025: $37.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $314 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $313.88 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $404.21 | 2022-2023 | Myrisk |
| Seagen INC. | $317.18 | 2021-2023 | Adcetris |
| Astellas Pharma US INC | $279.05 | 2022-2023 | |
| Janssen Biotech, INC. | $262.14 | 2021-2023 | |
| Incyte Corporation | $117.88 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $86.83 | 2022-2023 | Ninlaro |
| E.R. Squibb & Sons, L.L.C. | $66.14 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $53.54 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $34.59 | 2022-2023 | Somatuline Depot, Onivyde |
| Daiichi Sankyo INC. | $30.85 | 2022 | |
| Novartis Pharmaceuticals Corporation | $23.89 | 2023 | |
| Mylan Institutional INC. | $19.71 | 2022 | |
| Hologic Sales and Service, LLC | $19.55 | 2025 | Acessa Provu System |
| Exact Sciences Corporation | $18.39 | 2025 | The Cologuard Plus Collection Kit |
| G1 Therapeutics, INC. | $17.87 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $16.68 | 2023 | Keytruda |
| Genzyme Corporation | $15.68 | 2023 | |
| Servier Pharmaceuticals LLC | $14.11 | 2023 | |
| Puma Biotechnology, INC. | $12.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Murrey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.